This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2r0l

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2r0l.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2r0l.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2r0l| PDB=2r0l | SCENE= }}
{{STRUCTURE_2r0l| PDB=2r0l | SCENE= }}
-
'''Short Form HGFA with Inhibitory Fab75'''
+
===Short Form HGFA with Inhibitory Fab75===
-
==Overview==
+
<!--
-
To better understand how the relatively flat antigen-combining sites of antibodies interact with the concave shaped substrate-binding clefts of proteases, we determined the structures of two antibodies in complex with the trypsin-like hepatocyte growth-factor activator (HGFA). The two inhibitory antibodies, Ab58 and Ab75, were generated from a human Fab phage display library with synthetic diversity in the three complementarity determining regions (H1, H2, and H3) of the heavy chain, mimicking the natural diversity of the human Ig repertoire. Biochemical studies and the structures of the Fab58:HGFA (3.5-A resolution) and the Fab75:HGFA (2.2-A resolution) complexes revealed that Ab58 obstructed substrate access to the active site, whereas Ab75 allosterically inhibited substrate hydrolysis. In both cases, the antibodies interacted with the same protruding element (99-loop), which forms part of the substrate-binding cleft. Ab58 inserted its H1 and H2 loops in the cleft to occupy important substrate interaction sites (S3 and S2). In contrast, Ab75 bound at the backside of the cleft to a region corresponding to thrombin exosite II, which is known to interact with allosteric effector molecules. In agreement with the structural analysis, binding assays with active site inhibitors and enzymatic assays showed that Ab58 is a competitive inhibitor, and Ab75 is a partial competitive inhibitor. These results provide structural insight into antibody-mediated protease inhibition. They suggest that unlike canonical inhibitors, antibodies may preferentially target protruding loops at the rim of the substrate-binding cleft to interfere with the catalytic machinery of proteases without requiring long insertion loops.
+
The line below this paragraph, {{ABSTRACT_PUBMED_18077410}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 18077410 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_18077410}}
==About this Structure==
==About this Structure==
Line 35: Line 39:
[[Category: Serine protease]]
[[Category: Serine protease]]
[[Category: Zymogen]]
[[Category: Zymogen]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 16:01:45 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 00:42:49 2008''

Revision as of 21:42, 27 July 2008

Image:2r0l.png

Template:STRUCTURE 2r0l

Short Form HGFA with Inhibitory Fab75

Template:ABSTRACT PUBMED 18077410

About this Structure

2R0L is a Protein complex structure of sequences from [1] and Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structural insight into distinct mechanisms of protease inhibition by antibodies., Wu Y, Eigenbrot C, Liang WC, Stawicki S, Shia S, Fan B, Ganesan R, Lipari MT, Kirchhofer D, Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19784-9. Epub 2007 Dec 5. PMID:18077410

Page seeded by OCA on Mon Jul 28 00:42:49 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2r0l"
Personal tools